Identifying the "best" oncology companies typically depends on whether an evaluation focuses on commercial market share, robust drug pipelines, or breakthrough research innovations. Major industry pioneers like Merck (known for blockbuster immunotherapies), AstraZeneca (leading in targeted oncology treatments), and Roche (dominant in oncology diagnostics and antibody therapies) are widely regarded as industry leaders due to their extensive clinical portfolios and consistent global impact.